Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
MODD 
Modular Medical Inc (MODD)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/01/2025: MODD (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
Analysis of Past Performance
Type Stock | Historic Profit -53.44% | Avg. Invested days 29 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 04/01/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 57.98M USD | Price to earnings Ratio - | 1Y Target Price 8 |
Price to earnings Ratio - | 1Y Target Price 8 | ||
Volume (30-day avg) 107804 | Beta -3.97 | 52 Weeks Range 0.68 - 2.65 | Updated Date 04/1/2025 |
52 Weeks Range 0.68 - 2.65 | Updated Date 04/1/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.53 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) -125.28% | Return on Equity (TTM) -257.72% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 37846436 | Price to Sales(TTM) - |
Enterprise Value 37846436 | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA -3.21 | Shares Outstanding 53681400 | Shares Floating 30429784 |
Shares Outstanding 53681400 | Shares Floating 30429784 | ||
Percent Insiders 8.72 | Percent Institutions 44.95 |
Analyst Ratings
Rating 5 | Target Price 8 | Buy - | Strong Buy 1 |
Buy - | Strong Buy 1 | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Modular Medical Inc
Company Overview
History and Background
Modular Medical, Inc. was founded to develop and commercialize innovative, easy-to-use, and affordable technologies for diabetes management. They focus on simplified insulin delivery systems and related technologies.
Core Business Areas
- Insulin Delivery Systems: Development and potential commercialization of a novel, disposable insulin pump.
- Diabetes Technology: Research and development of technologies related to diabetes management.
Leadership and Structure
Details on the specific leadership team and organizational structure are often company confidential and constantly changing and therefore not possible to provide here.
Top Products and Market Share
Key Offerings
- Disposable Insulin Pump (in development): Modular Medical is developing a low-cost, disposable insulin pump designed to be simple and user-friendly. Market share data is unavailable as the product is not yet commercialized. Competitors include Medtronic (MDT), Insulet (PODD), Tandem Diabetes Care (TNDM), and numerous others.
Market Dynamics
Industry Overview
The insulin delivery market is experiencing growth driven by increasing diabetes prevalence and technological advancements. Key trends include the adoption of continuous glucose monitoring (CGM) integrated with insulin pumps, miniaturization, and user-friendly designs.
Positioning
Modular Medical aims to disrupt the insulin pump market by offering a more affordable and user-friendly disposable pump, differentiating itself from existing manufacturers with established market positions.
Total Addressable Market (TAM)
The global insulin pump market is projected to reach billions of dollars. Modular Medical's position relative to this TAM is dependent on the successful launch and adoption of its disposable pump. Specific TAM figures vary based on source, but generally estimate $6-8B by 2028.
Upturn SWOT Analysis
Strengths
- Potential for low-cost manufacturing
- User-friendly design
- Addresses unmet needs in insulin delivery
- Novel Technology
Weaknesses
- Lack of commercialized products
- Limited operating history
- Dependence on regulatory approvals
- High R&D expenses
- Highly competitive market
Opportunities
- Growing diabetes population
- Increasing demand for user-friendly insulin delivery systems
- Partnerships with diabetes care providers
- Expansion into new markets
- Adoption of closed-loop systems
Threats
- Competition from established players
- Technological obsolescence
- Regulatory hurdles
- Reimbursement challenges
- Economic downturn affecting healthcare spending
Competitors and Market Share
Key Competitors
- MDT
- PODD
- TNDM
Competitive Landscape
Modular Medical faces intense competition from established players with significant resources and market presence. Success depends on the novelty, cost-effectiveness, and user-friendliness of their disposable insulin pump.
Major Acquisitions
Growth Trajectory and Initiatives
Historical Growth: No historical growth data available, as they have no commercialized products.
Future Projections: Future growth is dependent on successful product development, regulatory approval, and market adoption. Analyst estimates are unavailable at this early stage.
Recent Initiatives: Focus on the continued development and clinical validation of their disposable insulin pump technology.
Summary
Modular Medical is a development-stage company with a potentially disruptive disposable insulin pump. Success hinges on overcoming regulatory hurdles, securing funding, and successfully commercializing its product in a highly competitive market. The company's innovative approach and focus on affordability could be advantages, but lack of established products and intense competition remain significant challenges. The company needs to focus on securing partnerships for the purpose of commercialization.
Similar Companies
- MDT
- PODD
- TNDM
Sources and Disclaimers
Data Sources:
- Company Website
- Public Filings
- Industry Reports
Disclaimers:
This analysis is based on publicly available information and is not financial advice. The information provided is for informational purposes only and should not be considered a recommendation to buy or sell any security. Market share data is based on approximations and estimates.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Modular Medical Inc
Exchange NASDAQ | Headquaters San Diego, CA, United States | ||
IPO Launch date 2007-01-25 | CEO - | ||
Sector Healthcare | Industry Medical Devices | Full time employees 39 | Website https://www.modularmedical.com |
Full time employees 39 | Website https://www.modularmedical.com | ||
Modular Medical, Inc. operates as a medical device company. It focuses on the design, development, and commercialization of insulin pumps. It offers MODD1, a two-part patch pump for type-1 and type-2 diabetes. The company is headquartered in San Diego, California.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.